Evogene (EVGN) vs Nutrien (NTR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Nutrien is the larger company by market cap ($30.27 billion vs $5.7 million), about 5302.7 times the size. Nutrien pays a dividend yielding 3.43%, while Evogene does not currently pay one. Nutrien converts more of its revenue into profit, with a net margin of 8.4% versus -220.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EVGN | NTR |
|---|---|---|
| Share price | $0.3162 | $63.84 |
| Market cap | $5.71M | $30.27B |
| 1-day change | +1.02% | -2.40% |
| YTD return | — | +3.43% |
| 1-year return | — | +13.61% |
| 5-year return | — | -5.67% |
| P/E ratio (TTM) | — | 13.94 |
| Forward P/E | — | 12.50 |
| EPS (TTM) | $-1.55 | $4.58 |
| Dividend yield | 0.00% | 3.43% |
| Annual dividend | $0.00 | $2.19 |
| Revenue (latest FY) | $3.85M | $26.89B |
| Revenue growth (YoY) | -30.91% | +3.52% |
| Net income (latest FY) | $-8.48M | $2.27B |
| Gross margin | -6.25% | 31.05% |
| Operating margin | -364.24% | 13.90% |
| Net margin | -220.22% | 8.43% |
| 52-week high | $1.26 | $85.36 |
| 52-week low | $0.25 | $55.48 |
| Distance from 52-week high | -74.90% | -25.21% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +579.95% | +21.38% |
| Average volume | 1.40M | 2.38M |
| Shares outstanding | 18.05M | 474.13M |
| Employees | 38 | — |
| Sector | Industrials | Industrials |
| Industry | Agricultural Chemicals | Agricultural Chemicals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Nutrien is about 5302.7 times larger than Evogene by market value ($30.27B vs $5.71M).
- Nutrien offers a meaningfully higher dividend yield (3.43% vs 0.00%).
- Nutrien is more profitable, keeping 8.4 cents of every revenue dollar as net income versus -220.2 cents for Evogene.
- Nutrien grew revenue faster in its latest fiscal year (+3.52% vs -30.91%).
About Evogene
EVGN stock →Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications.
Industrials · Agricultural Chemicals · 38 employees
About Nutrien
NTR stock →Nutrien Ltd. provides crop inputs and services.
Industrials · Agricultural Chemicals
EVGN vs NTR FAQ
Which is bigger, Evogene or Nutrien?
Nutrien (NTR) is larger, with a market capitalization of $30.27B compared with $5.71M for Evogene (EVGN).
Which pays a higher dividend, Evogene or Nutrien?
Nutrien pays a dividend yielding 3.43%, while Evogene does not currently pay a regular dividend.
Are Evogene and Nutrien in the same industry?
Yes. Both are classified in the Agricultural Chemicals industry within the Industrials sector.